Genetic variability and phylogeny of high risk HPV type 16, 18, 31, 33 and 45 L1 gene in Greek women

International Journal of Molecular Sciences

Volumn 13, Issue 1, 2012, Pages 1-17

  Ntova, Chara Kleio ^a   Kottaridi, Christine ^a   Chranioti, Aikaterini ^a   Spathis, Aris ^a   Kassanos, Dimitrios ^a   Paraskevaidis, Evangelos ^b   Karakitsos, Petros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

Cervical neoplasia; Greece; High risk; HPV; Phylogeny

Indexed keywords

ARTICLE; BAYES THEOREM; CANCER RISK; CLADISTICS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; GREECE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; L1 GENE; MAJOR CLINICAL STUDY; MARKER GENE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PARSIMONY ANALYSIS; PHYLOGENY; POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS IDENTIFICATION; VIRUS TYPING; ALPHAPAPILLOMAVIRUS; AMINO ACID SEQUENCE; CAUCASIAN; CLASSIFICATION; GENETICS; GENOTYPE; PATHOLOGY; RISK FACTOR; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ALPHAPAPILLOMAVIRUS; AMINO ACID SEQUENCE; BAYES THEOREM; CERVIX UTERI; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC VARIATION; GENOTYPE; GREECE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMAN PAPILLOMAVIRUS 31; HUMANS; PHYLOGENY; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; WOMEN;

EID: 84856247449     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13010001     Document Type: Article

References (48)

1. Li, N.; Franceschi, S.; Howell-Jones, R.; Snijders, P.J.; Clifford, G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int. J. Cancer 2011, 128, 927-935.
2. Munoz, N.; Bosch, F.X.; de Sanjose, S.; Herrero, R.; Castellsague, X.; Shah, K.V.; Snijders, P.J.; Meijer, C.J. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003, 348, 518-527.
3. Schiffman, M.; Herrero, R.; Desalle, R.; Hildesheim, A.; Wacholder, S.; Rodriguez, A.C.; Bratti, M.C.; Sherman, M.E.; Morales, J.; Guillen, D.; et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005, 337, 76-84.
4. Bernard, H.U.; Burk, R.D.; Chen, Z.; van Doorslaer, K.; Hausen, H.; de Villiers, E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401, 70-79.
5. de Villiers, E.M.; Fauquet, C.; Broker, T.R.; Bernard, H.U.; zur Hausen, H. Classification of papillomaviruses. Virology 2004, 324, 17-27.
6. Chen, Z.; DeSalle, R.; Schiffman, M.; Herrero, R.; Burk, R.D. Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97. J. Virol. 2009, 83, 1443-1455.
7. Chen, Z.; Schiffman, M.; Herrero, R.; Desalle, R.; Anastos, K.; Segondy, M.; Sahasrabuddhe, V.V.; Gravitt, P.E.; Hsing, A.W.; Burk, R.D. Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 2011, 6, doi:10.1371/journal.pone.0020183.
8. Nylander, J.A.A. Mrmodeltest 2.3. Program Distributed by the Author; Uppsala University: Uppsala, Switzerland, 2004.
9. Yamada, T.; Wheeler, C.M.; Halpern, A.L.; Stewart, A.C.; Hildesheim, A.; Jenison, S.A. Human papillomavirus type 16 variant lineages in united states populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 1995, 69, 7743-7753.
10. Calleja-Macias, I.E.; Villa, L.L.; Prado, J.C.; Kalantari, M.; Allan, B.; Williamson, A.L.; Chung, L.P.; Collins, R.J.; Zuna, R.E.; Dunn, S.T.; et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J. Virol. 2005, 79, 13630-13640.
11. Stewart, A.C.; Eriksson, A.M.; Manos, M.M.; Munoz, N.; Bosch, F.X.; Peto, J.; Wheeler, C.M. Intratype variation in 12 human papillomavirus types: A worldwide perspective. J. Virol. 1996, 70, 3127-3136.
12. Tamura, K.; Dudley, J.; Nei, M.; Kumar, S. Mega4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24, 1596-1599.
13. Swofford, D.L. Paup*: Phylogenetic Analysis Using Parsimony (and Other Methods), Version 4.0b10; Sinauer Associates: Sunderland, MA, USA, 2002.
14. Felsenstein, J. Confidence limits on phylogenies: An approach using the bootstrap. Evolution 1985, 39, 783-791.
15. Ronquist, F.; Huelsenbeck, J.P. Mrbayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 2003, 19, 1572-1574.
16. Akaike, H. A new look at the statistical model identification. IEEE Trans. Autom. Control 1974, 19, 716-723.
17. Xia, X.; Xie, Z. Dambe: Software package for data analysis in molecular biology and evolution. J. Hered. 2001, 92, 371-373.
18. Page, R.D. Treeview: An application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 1996, 12, 357-358.
19. HPV Sequence Database. Available online: http://hpv-web.lanl.gov/ (accessed on 3 July 2011).
20. Bernard, H.U.; Chan, S.Y.; Delius, H. Evolution of papillomaviruses. Curr. Top. Microbiol. Immunol. 1994, 186, 33-54.
21. Zehbe, I.; Wilander, E.; Delius, H.; Tommasino, M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58, 829-833.
22. Hildesheim, A.; Schiffman, M.; Bromley, C.; Wacholder, S.; Herrero, R.; Rodriguez, A.; Bratti, M.C.; Sherman, M.E.; Scarpidis, U.; Lin, Q.Q.; et al. Human papillomavirus type 16 variants and risk of cervical cancer. J. Natl. Cancer Inst. 2001, 93, 315-318.
23. Pista, A.; Oliveira, A.; Barateiro, A.; Costa, H.; Verdasca, N.; Paixao, M.T. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in portugal. J. Med. Virol. 2007, 79, 1889-1897.
24. Ellis, J.R.; Keating, P.J.; Baird, J.; Hounsell, E.F.; Renouf, D.V.; Rowe, M.; Hopkins, D.; Duggan-Keen, M.F.; Bartholomew, J.S.; Young, L.S.; et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1995, 1, 464-470.
25. Cheng, G.; Icenogle, J.P.; Kirnbauer, R.; Hubbert, N.L.; St. Louis, M.E.; Han, C.; Svare, E.I.; Kjaer, S.K.; Lowy, D.R.; Schiller, J.T. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J. Infect. Dis. 1995, 172, 1584-1587.
26. Hildesheim, A. Human papillomavirus variants: Implications for natural history studies and vaccine development efforts. J. Natl. Cancer Inst. 1997, 89, 752-753.
27. Park, J.S.; Hwang, E.S.; Lee, C.J.; Kim, C.J.; Rha, J.G.; Kim, S.J.; Namkoong, S.E.; Um, S.J. Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol. Oncol. 1999, 74, 23-29.
28. Kammer, C.; Warthorst, U.; Torrez-Martinez, N.; Wheeler, C.M.; Pfister, H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for p97 promoter activity. J. Gen. Virol. 2000, 81, 1975-1981.
29. Ho, L.; Chan, S.Y.; Burk, R.D.; Das, B.C.; Fujinaga, K.; Icenogle, J.P.; Kahn, T.; Kiviat, N.; Lancaster, W.; Mavromara-Nazos, P.; et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 1993, 67, 6413-6423.
30. Wheeler, C.M.; Yamada, T.; Hildesheim, A.; Jenison, S.A. Human papillomavirus type 16 sequence variants: Identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol. 1997, 35, 11-19.
31. Chen, Z.; Terai, M.; Fu, L.; Herrero, R.; DeSalle, R.; Burk, R.D. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J. Virol. 2005, 79, 7014-7023.
32. Bosch, F.X.; Manos, M.M.; Munoz, N.; Sherman, M.; Jansen, A.M.; Peto, J.; Schiffman, M.H.; Moreno, V.; Kurman, R.; Shah, K.V. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J. Natl. Cancer Inst. 1995, 87, 796-802.
33. Wu, Y.; Chen, Y.; Li, L.; Yu, G.; Zhang, Y.; He, Y. Associations of high-risk hpv types and viral load with cervical cancer in china. J. Clin. Virol. 2006, 35, 264-269.
34. Das, B.C.; Sharma, J.K.; Gopalkrishna, V.; Das, D.K.; Singh, V.; Gissmann, L.; zur Hausen, H.; Luthra, U.K. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by southern blot hybridization and polymerase chain reaction. J. Med. Virol. 1992, 36, 239-245.
35. Tornesello, M.L.; Duraturo, M.L.; Buonaguro, L.; Vallefuoco, G.; Piccoli, R.; Palmieri, S.; Buonaguro, F.M. Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy. Infect. Agent Cancer 2007, 2, doi:10.1186/1750-9378-2-1.
36. Pillai, M.R.; Hariharan, R.; Babu, J.M.; Lakshmi, S.; Chiplunkar, S.V.; Patkar, M.; Tongaonkar, H.; Dinshaw, K.; Jayshree, R.S.; Reddy, B.K.; et al. Molecular variants of HPV-16 associated with cervical cancer in indian population. Int. J. Cancer 2009, 125, 91-103.
37. Daponte, A.; Pournaras, S.; Mademtzis, I.; Hadjichristodoulou, C.; Kostopoulou, E.; Maniatis, A.N.; Messinis, I.E. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J. Clin. Virol. 2006, 36, 189-193.
38. Konidaris, S.; Kouskouni, E.E.; Panoskaltsis, T.; Kreatsas, G.; Patsouris, E.S.; Sarivalassis, A.; Nonni, A.; Lazaris, A.C. Human papillomavirus infection in malignant and benign gynaecological conditions: A study in Greek women. Health Care Women Int. 2007, 28, 182-191.
39. Kroupis, C.; Thomopoulou, G.; Papathomas, T.G.; Vourlidis, N.; Lazaris, A.C. Population-based study of human papillomavirus infection and cervical neoplasia in Athens, Greece. Epidemiol. Infect. 2007, 135, 943-950.
40. Yapijakis, C.; Adamopoulou, M.; Antonopoulos, G.; Koufaliotis, N.; Vairaktaris, E. Prevalence of HPV types in a cohort of Greeks with clinical indication of infection. Anticancer Res. 2008, 28, 2233-2237.
41. Villa, L.L.; Sichero, L.; Rahal, P.; Caballero, O.; Ferenczy, A.; Rohan, T.; Franco, E.L. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J. Gen. Virol. 2000, 81, 2959-2968.
42. Tornesello, M.L.; Duraturo, M.L.; Salatiello, I.; Buonaguro, L.; Losito, S.; Botti, G.; Stellato, G.; Greggi, S.; Piccoli, R.; Pilotti, S.; et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J. Med. Virol. 2004, 74, 117-126.
43. Ong, C.K.; Chan, S.Y.; Campo, M.S.; Fujinaga, K.; Mavromara-Nazos, P.; Labropoulou, V.; Pfister, H.; Tay, S.K.; ter Meulen, J.; Villa, L.L.; et al. Evolution of human papillomavirus type 18: An ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 1993, 67, 6424-6431.
44. Altekruse, S.F.; Lacey, J.V., Jr.; Brinton, L.A.; Gravitt, P.E.; Silverberg, S.G.; Barnes, W.A., Jr.; Greenberg, M.D.; Hadjimichael, O.C.; McGowan, L.; Mortel, R.; et al. Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am. J. Obstet. Gynecol. 2003, 188, 657-663.
45. Burk, R.D.; Terai, M.; Gravitt, P.E.; Brinton, L.A.; Kurman, R.J.; Barnes, W.A.; Greenberg, M.D.; Hadjimichael, O.C.; Fu, L.; McGowan, L.; et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 2003, 63, 7215-7220.
46. Schlecht, N.F.; Burk, R.D.; Palefsky, J.M.; Minkoff, H.; Xue, X.; Massad, L.S.; Bacon, M.; Levine, A.M.; Anastos, K.; Gange, S.J.; et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J. Gen. Virol. 2005, 86, 2709-2720.
47. Xi, L.F.; Koutsky, L.A.; Hildesheim, A.; Galloway, D.A.; Wheeler, C.M.; Winer, R.L.; Ho, J.; Kiviat, N.B. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol. Biomark. Prev. 2007, 16, 4-10.
48. Cerqueira, D.M.; Raiol, T.; Veras, N.M.; von Gal Milanezi, N.; Amaral, F.A.; de Macedo Brigido, M.; Martins, C.R. New variants of human papillomavirus type 18 identified in central Brazil. Virus Genes 2008, 37, 282-287.